|
| | Fraxamoside Basic information |
| Product Name: | Fraxamoside | | Synonyms: | Fraxamoside;2H-Pyran-4-acetic acid, 2-[[6-O-[(1R)-1-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-β-D-glucopyranosyl]oxy]-3-ethylidene-3,4-dihydro-5-(methoxycarbonyl)-, intramol. 4,2''-ester, (2S,3E,4S)- | | CAS: | 326594-34-7 | | MF: | C25H30O13 | | MW: | 538.5 | | EINECS: | | | Product Categories: | | | Mol File: | 326594-34-7.mol |  |
| | Fraxamoside Chemical Properties |
| Boiling point | 825.8±65.0 °C(Predicted) | | density | 1.468±0.06 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 9.44±0.10(Predicted) |
| | Fraxamoside Usage And Synthesis |
| Description | Fraxamoside shows significant free radical scavenging effect against DPPH(EC50=66 uM).
Fraxamoside is a xanthine oxidase inhibitor (XOI) comparable in potency in vitro to the standard antigout drug allopurinol. |
| | Fraxamoside Preparation Products And Raw materials |
|
